Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Knumb Knuts Extraordinaire
View:
Post by SWNE on Jun 25, 2013 7:20pm

Knumb Knuts Extraordinaire

There is no doubt now, that Graeme et al, want to sell AH to take Urocidin to the finish line. Graeme et al, are the additional 12M shares wanting to wait until the Nov. 5 AGM circumventing the Biovail Boys from forcing a meeting earlier.

This means there are a substantial number of voters wanting to allow time to sell AH.

This also means that Graeme et al, are willing to blow everything on Urocidin. This can be seen as a good sign, but also a chrapp shoot.

My bet is that upon the sale of AH, there will be no dividend, because Graeme will hold all the cash for future burn, and we will see no sustained increase in our dismal share price. Therefore, whichever way you take this company, you will only make money if Urocidin strikes pay dirt. Endo dumped Urocidin en masse, and they knew its potential.

Frankly, the future looks bleak for all of us aching long term investors.
Comment by Nohandledzep on Jun 25, 2013 10:34pm
Swine... Don't forget that court date of July 18. Something tells me that this 12 million shares might be all they can muster, and I question the stability of each and everyone of those. How many times can McRae plead and succeed in his quest for more time, only to come up empty? Now, if he pulls GMP out of a hat before the AH sale or the meeting date is set, things may change. But since ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities